Киареста

Киареста (Anastrozole) is an oral aromatase inhibitor used in hormone receptor-positive breast cancer therapy. This non-steroidal medication helps reduce estrogen levels in postmenopausal women. Suitable for adjuvant treatment and metastatic cases. Always consult a healthcare professional before use.

Anastrozole is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels, which can slow or stop the growth of certain cancer cells. This medication is often prescribed as adjuvant therapy after surgery or for advanced cancer cases. It may also be used off-label for other estrogen-sensitive conditions under medical supervision.

Common effects of Anastrozole include hot flashes, joint pain, and fatigue. Some users may experience mild nausea or headaches. These effects are typically temporary and vary by individual. Mood changes, such as depression or anxiety, have also been reported. Always monitor your body’s response and discuss concerns with a healthcare provider.

Store Anastrozole at room temperature away from moisture and direct light. Keep out of reach of children and pets. Do not use if the packaging is damaged or the seal is broken. If you miss a dose, take it as soon as you remember unless it’s almost time for the next dose. Never double up on doses to compensate.

Anastrozole may interact with estrogen-containing medications, tamoxifen, or other CYP3A4 inhibitors. Alcohol and certain herbal supplements (like St. John’s Wort) may also affect its efficacy. Always inform your doctor about all medications and supplements you’re taking. Grapefruit juice may alter drug levels in the bloodstream. Monitor for unusual symptoms when combining with other therapies.